J Rheumatol:系统性红斑狼疮的疲劳指标

2019-06-29 xiangting MedSci原创

VAS、FSS和FACIT-疲劳量表是2008年至2017年成人SLE研究中最常用的工具。

疲劳是系统性红斑狼疮(SLE)常见并影响日常活动的问题。但是,疲劳很难量化。2007年SLE疲劳反应标准特设委员会建议使用克虏伯疲劳严重程度量表(FSS)。从那时起,慢性疾病治疗功能评估(FACIT) -疲劳量表也在SLE中得到验证。这项研究对2007年以来测量成人SLE患者疲劳所用的工具进行了综述。

研究人员检索了PubMed、Medline和Embase(2008年1月至2017年10月),确定把疲劳作为特别测量结局的成人SLE临床试验和观察性研究。对所有英语和法语研究进行了回顾,以确定疲劳指标和结果。

37项研究符合纳入标准。使用了8个量表。视觉模拟量表(VAS)、FSS和FACIT-疲劳量表最常见。FSS是临床试验和观察性研究中最常用的工具。37项研究中有25项表明疲劳程度的差异具有统计学意义和临床意义。其余12项研究中,6项使用了FSS,3项使用了VAS,2项使用了多维疲劳评估,1项使用了短暂疲劳指数。所有6项使用FACIT-疲劳量表的研究都发现了具有临床意义和统计学意义的差异。

VAS、FSS和FACIT-疲劳量表是2008年至2017年成人SLE研究中最常用的工具。许多研究发现了临床上重要的疲劳变化。疲劳仍然是临床试验和观察性SLE研究的关键指标。

原始出处:
Ariane Barbacki. Fatigue Measurements in Systemic Lupus Erythematosus. J Rheumatol. June 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2017161, encodeId=9261201e161c8, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 31 20:48:00 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260903, encodeId=3258126090372, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387353, encodeId=a7de138e353f7, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436224, encodeId=bb3d143622400, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2017161, encodeId=9261201e161c8, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 31 20:48:00 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260903, encodeId=3258126090372, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387353, encodeId=a7de138e353f7, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436224, encodeId=bb3d143622400, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2019-07-01 tamgche
  3. [GetPortalCommentsPageByObjectIdResponse(id=2017161, encodeId=9261201e161c8, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 31 20:48:00 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260903, encodeId=3258126090372, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387353, encodeId=a7de138e353f7, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436224, encodeId=bb3d143622400, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2017161, encodeId=9261201e161c8, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun May 31 20:48:00 CST 2020, time=2020-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260903, encodeId=3258126090372, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387353, encodeId=a7de138e353f7, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68144, encryptionId=8a3a6814425, topicName=狼疮)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a6e2500005, createdName=sunrural_42825357, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1436224, encodeId=bb3d143622400, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77123, encryptionId=22f8e71238d, topicName=红斑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 01 02:48:00 CST 2019, time=2019-07-01, status=1, ipAttribution=)]

相关资讯

J Rheumatol:SLE和狼疮性肾炎患者的中性粒细胞胞外陷阱(NETs)

在血管炎(SVV)中,中性粒细胞胞外陷阱(NETs)将修饰的抗原暴露于自身抗体。关于系统性红斑狼疮(SLE)的NETs水平和去除途径知之甚少,尤其是狼疮性肾炎(LN)。这项研究在大型偶发性SLE患者亚组中确定了NETs循环水平并定义了去除率,其中部分患者为新发肾炎。测定了216例偶发性SLE患者(其中103例有偶发性LN)、50例原发性肾小球肾炎患者和健康对照的血清NETs水平(ELISA)、DN

Arthritis Rheumatol:SLE患者直系亲属血浆微生物易位、微生物组与出现自身抗体的关联

这些结果表明血浆微生物易位和微生物组成可能在影响SLE自身抗体产生中起作用。

J Rheumatol:系统性红斑狼疮的血压变异性和年龄相关血压模式

SLE中的年龄相关血压模式与一般人群不同。

J Rheumatol:儿童期虐待与成年患系统性红斑狼疮的关联

与未受到虐待的女性相比,儿童期受到身体和情感虐待的女性患SLE风险明显升高。儿童期遭遇不幸有助于SLE的发展。

J Rheumatol:系统性红斑狼疮中的动脉粥样硬化血管事件

由于对经典冠脉危险因素和SLE的有效治疗,现代SLE的AVE发病率有明显下降。

Arthritis Rheumatol:利妥昔单抗作为系统性红斑狼疮维持治疗的观察性研究

RMT是难治性患者的潜在治疗选择。首次RTX时有活动性关节病的患者更容易在RMT期间复发。